Literature DB >> 1032826

Niflumic acid in the management of rheumatoid and osteoarthritis.

G H Tilve, J K Lengade, A V Bavadekar, K G Nair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1032826

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  2 in total

1.  Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.

Authors:  Shengqun Luo; Guoliang Huang; Ziyou Wang; Zheng Wan; Hua Chen; Dan Liao; Chuyan Chen; Huahui Li; Binbin Li; Liyong Chen; Zunnan Huang; Zhiwei He
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Identification of the hypertension drug niflumic acid as a glycine receptor inhibitor.

Authors:  Daishi Ito; Yoshinori Kawazoe; Ayato Sato; Motonari Uesugi; Hiromi Hirata
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.